Health inspection·July 21, 2025

F 0761 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Some Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional principles; and all drugs and biologicals must be stored in locked compartments, separately locked, compartments for controlled drugs. Based on observation interviews and policy review, the facility did not ensure medications were stored and labeled appropriately in three medication carts (Split back, East front and [NAME] front) of three medication carts observed. Findings included: 1. An observation on 7/21/2025 at 2:25 P.M. of the Split Back Cart Medication Cart revealed an undated used bottle of Latanoprost eye drops, two undated Breo Inhalers and an undated Combivent inhaler. The boxes containing the Breo inhalers were labeled expires six weeks after opening and the Combivent inhaler was labeled expires three months after opening. The boxes did not show an opening date.An interview was conducted with Staff B, Licensed Practical Nurse (LPN) on 7/21/2025 at 2:32 P.M. She stated if she found medications that were not labeled in the medication cart, she would discuss it with the shift supervisor. She stated she never discards medications from the medication cart without speaking to a supervisor. The nurse placed all the undated medications back into the medication cart. Staff B, LPN stated it was her second day working at the facility and she did know what pharmacy they use. 2. An observation on 7/21/2025 at 2:37 P.M. of the East Front Medication Cart revealed a bottle of Ibuprofen which was opened. There was no date to indicate when the bottle was opened.An interview was conducted with Staff A, LPN on 7/21/2025 at 2:43 P.M. She stated the medication was probably opened today. Staff A proceeded to label the medication with a date of 7/21/2025. She stated she did not give this medication to any residents today. 3. An observation on 7/21/2025 at 3:00 P.M. of the [NAME] Front Medication Cart revealed an undated empty bottle of Omeprazole which was in the top drawer of the cart, an undated used bottle of Latanoprost eye drops, two undated used bottles of Loteprednol eye drops, an undated used bottle of Timolol eye drops and an undated used Breo Inhaler. The box the inhaler was stored in read, expires six weeks after opening. There was no date to indicate when the bottle was opened.An interview was conducted with the Director of Nursing (DON) on 7/21/2025 at 3:08 P.M. She said all medications should be labeled with the date it was opened and the expiration date. She said the inhalers always expire before the printed manufacturer's date on the inhaler box, if they are opened. She stated the facility had a lot of agency staff at this time, but they were trying to recruit permanent staff. The DON stated her expectations were for the nurses to follow the pharmacy's recommended expiration dates.A review of the facility policy titled Medication Labeling and Storage reviewed on 3/2023 revealed, The facility stores all medications and biologicals in locked compartments under proper temperature, humidity and light controls. Only authorized personnel have access to keys. The policy and interpretation and Implementation section titled, Medication Labeling showed: 1. Labeling of the medications and biological dispensed by the pharmacy is consistent with applicable federal and state requirements and currently accepted pharmaceutical practices. 2. The medication label includes, at a minimum: d: expiration date and g: appropriate instructions and precautions. 8: If the medication containers have missing, incomplete, improper or (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 2 Event ID: 105712 Printed: 05/28/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 105712 B. Wing A. Building (X3) DATE SURVEY COMPLETED 07/21/2025 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Alhambra Healthcare & Rehabilitation Center 7501 38th Ave N Saint Petersburg, FL 33710 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)